Continue to Site

Pharmaceutical Processing World

Bayer announces €3 million disaster relief fund for Ukraine

By |

Bayer supporting Ukraine

Image courtesy of Bayer

Bayer (ETR:BAYN) will offer additional support to international and local humanitarian aid organizations serving Ukraine and neighboring countries.

Immediately after Russia’s invasion of Ukraine, Bayer had pledged to spend €300,000 in aid. Now, it has committed €3 million in additional humanitarian aid.

Roche, Sanofi and Novo Nordisk have announced similar initiatives for Ukraine.

Bayer has successfully shipped antibiotics and sterile medical items to the war-ravaged country.

In addition, Bayer employees have donated more than €600,000 in additional funding for Ukraine. The company has vowed to match employees’ donations.

Soon after the invasion, Bayer CEO Werner Baumann vowed to do “everything in our power to support our colleagues and their families in Ukraine.”

Bayer also has given cash to support its employees based in Ukraine.

The trade organization PhRMA has also stressed the importance of continuing to make medications available in Ukraine during the crisis.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think!

Related Articles Read More >

Search Pharmaceutical Processing World